Allianz Asset Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
– Sell
-6,032,141
Closed -$4.09M – 2646
2015
Q1
$4.09M Sell
6,032,141
-4,704
-0.1% -$3.29K ﹤0.01% 1293
2014
Q4
$4.77M Sell
6,036,845
-102,569
-2% -$70.1K 0.01% 1236
2014
Q3
$2.85M Buy
6,139,414
+183,562
+3% +$89.1K ﹤0.01% 1302
2014
Q2
$2.98M Buy
5,955,852
+2,110,867
+55% +$1.02M ﹤0.01% 1068
2014
Q1
$1.23M Sell
3,844,985
-688,131
-15% -$256K ﹤0.01% 1348
2013
Q4
$1.54M Sell
4,533,116
-209,538
-4% -$253K ﹤0.01% 1283
2013
Q3
$9.58M Sell
4,742,654
-65,611
-1% -$125K 0.01% 689
2013
Q2
$9.28M Buy
+4,808,265
New +$8.45M 0.01% 661

Other funds holding GCVRZ

Allianz Asset Management's GCVRZ Position: Q2 2015 in Review

Allianz Asset Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q2 2015, closing a stake of 6,032,141 shares — an estimated $4.09M sold.

Allianz Asset Management first reported a position in GCVRZ in Q2 2013 and held it in 8 quarters. The position peaked at $9.58M in Q3 2013. 116 funds tracked by Wall St. Rank hold GCVRZ as of Q2 2015.

  • Allianz Asset Management reported no remaining Sanofi Contingent Value Rights position as of Q2 2015 after selling out during the quarter.
  • Allianz Asset Management sold 6,032,141 Sanofi Contingent Value Rights shares in Q2 2015, an estimated $4.09M.
  • Allianz Asset Management first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 8 quarters.
  • Allianz Asset Management's Sanofi Contingent Value Rights position peaked at $9.58M in Q3 2013.
  • 116 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q2 2015.

Based on Allianz Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.